New study aims to improve monitoring of rheumatoid arthritis with simple blood tests and ultrasound

NCT ID NCT07272850

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare blood test results and ultrasound images of joints in 72 people with rheumatoid arthritis. Half are taking JAK inhibitors, and half are on traditional treatments. The goal is to see if certain blood markers can reliably show how active the disease is, which could make monitoring easier and more accurate.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
JAK inhibitors
What this could lead to
If successful, this could help doctors better monitor rheumatoid arthritis activity using simple blood tests and ultrasound, potentially guiding more personalized treatment decisions.
What could go wrong
This is a small, observational study that does not test a new treatment. It may not produce clear or widely applicable results due to its limited size and design.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.